Drug shortage
Carboplatin Injection · Teyro Labs
FDA drug shortage · To Be Discontinued · updated Mar 28, 2025
Key facts
| Generic name | Carboplatin Injection |
|---|---|
| Company | Teyro Labs |
| Presentation | Carboplatin, Injection, 10 mg/1 mL (NDC 60505-6282-3) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Oncology |
| Package NDCs | 60505-6282-3 |
| First posted | Mar 28, 2025 |
| Last updated | Mar 28, 2025 |
| Discontinued | Mar 28, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: